Affymetrix Inc (AFFX)

14.01
0.02 0.14
NASDAQ : Technology
Prev Close 13.99
Open 14.03
Day Low/High 14.00 / 14.05
52 Wk Low/High 8.28 / 16.15
Volume 5.03M
Avg Volume 3.49M
Exchange NASDAQ
Shares Outstanding 80.54M
Market Cap 1.13B
EPS 0.13
P/E Ratio 107.61
Div & Yield N.A. (N.A)
AFFYMETRIX INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Believe The Acquisition By Thermo Fisher Scientific Inc. May Be Unfair To Shareholders

AFFYMETRIX INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Believe The Acquisition By Thermo Fisher Scientific Inc. May Be Unfair To Shareholders

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Affymetrix Inc.

Thermo Fisher Can Afford More Deals After Affymetrix Buy

Thermo Fisher Can Afford More Deals After Affymetrix Buy

The medical device maker is paying 20 times Ebitda for the specialty diagnostics company. Still, analysts believe the company is financially nimble enough for even more deals.

Bio-Genesys And Affymetrix Partner To Offer Animal Genomic Testing Services To Professional Farming Operations

Bio-Genesys And Affymetrix Partner To Offer Animal Genomic Testing Services To Professional Farming Operations

Affymetrix, Inc. (NASDAQ:AFFX) and United Kingdom-based Bio-Genesys Diagnostics announced today that they have entered a partnership to offer commercial genotyping services.

Affymetrix (AFFX) Stock Soars on $1.3 Billion Sale to Thermo Fisher Scientific

Affymetrix (AFFX) Stock Soars on $1.3 Billion Sale to Thermo Fisher Scientific

Affymetrix (AFFX) stock is surging on heavy trading volume on Monday after the company announced it was being acquired by Thermo Fisher Scientific for about $1.3 billion.

Thermo Fisher’s AFFX Buy Is a Boon For Shareholders

We believe the acquisition is a good strategic fit for the company.

Thermo Fisher Scientific To Acquire Affymetrix

Thermo Fisher Scientific To Acquire Affymetrix

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and Affymetrix Inc.

Thermo Fisher Scientific To Acquire Affymetrix

Thermo Fisher Scientific To Acquire Affymetrix

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Affymetrix Inc.

Affymetrix Expands Agrigenomics Genotyping Portfolio With New Targeted Sequencing Solution And Array Formats

Affymetrix Expands Agrigenomics Genotyping Portfolio With New Targeted Sequencing Solution And Array Formats

Affymetrix, Inc. (NASDAQ:AFFX) is introducing several new agrigenomic genotyping solutions this week at the annual Plant and Animal Genome Conference (PAG XXIV).

Affymetrix (AFFX) Strong On High Relative Volume Today

Affymetrix (AFFX) Strong On High Relative Volume Today

Trade-Ideas LLC identified Affymetrix (AFFX) as a strong on high relative volume candidate

Affymetrix (AFFX) Flagged As Strong On High Volume

Affymetrix (AFFX) Flagged As Strong On High Volume

Trade-Ideas LLC identified Affymetrix (AFFX) as a strong on high relative volume candidate

Affymetrix And Reveal Biosciences Partner To Offer RNA ISH Tissue Staining, Imaging, And Image Analysis Services

Affymetrix And Reveal Biosciences Partner To Offer RNA ISH Tissue Staining, Imaging, And Image Analysis Services

Affymetrix Inc. (NASDAQ:AFFX) and Reveal Biosciences LLC, an advanced tissue technologies company, today announced a partnership agreement through which Reveal will use Affymetrix ViewRNA® ISH products...

Affymetrix Reports New Employee Stock Grants

Affymetrix Reports New Employee Stock Grants

Affymetrix (NASDAQ:AFFX) today announced that equity awards were made to 5 new non-executive officer employees as inducement to join Affymetrix.

USDA, Aviagen, Hendrix Genetics, And Affymetrix Launch Axiom® Turkey Genotyping Array For Improved Breeding Outcome

USDA, Aviagen, Hendrix Genetics, And Affymetrix Launch Axiom® Turkey Genotyping Array For Improved Breeding Outcome

Affymetrix, Inc. (NASDAQ: AFFX) introduces Axiom ® Turkey Genotyping Array, developed in collaboration with the United States Department of Agriculture - Agricultural Research Service (USDA-ARS) along with...

Affymetrix And XRGenomics LTD To Collaborate On Development Of A New Generation Of Diagnostic Tests For Age-Related Diseases

Affymetrix And XRGenomics LTD To Collaborate On Development Of A New Generation Of Diagnostic Tests For Age-Related Diseases

Affymetrix, Inc. (NASDAQ: AFFX) and XRGenomics LTD, a UK based biotechnology company, announced today that they will collaborate on research and development of a new generation of diagnostic tests for age-related...

Affymetrix Reports Third Quarter 2015 Operating Results

Affymetrix Reports Third Quarter 2015 Operating Results

Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the third quarter of 2015.

Affymetrix And Athletigen Partner To Advance Genetics In Human Athletic Performance

Affymetrix And Athletigen Partner To Advance Genetics In Human Athletic Performance

Affymetrix Inc. (NASDAQ: AFFX) and Athletigen Technologies Inc.

Affymetrix And Luminex Announce Distribution Agreement For Multiplexed Assay Instrument Platform

Affymetrix And Luminex Announce Distribution Agreement For Multiplexed Assay Instrument Platform

Affymetrix Inc. (NASDAQ: AFFX) and Luminex Corporation (NASDAQ: LMNX) today announced a distribution agreement under which eBioscience, a business unit of Affymetrix, will sell Luminex's MAGPIX ®,...

Affymetrix Introduces Axiom Transplant Genotyping Array For Genomic Profiling Of Immune-Related Markers

Affymetrix Introduces Axiom Transplant Genotyping Array For Genomic Profiling Of Immune-Related Markers

Affymetrix (NASDAQ:AFFX) introduces Axiom ® Transplant Genotyping Array, designed in collaboration with an international team of surgeons and scientists for research studies to improve transplantation success and...

New Affymetrix HLA Analysis Software Quickly Delivers High-Resolution HLA Types From Genotyping Data

New Affymetrix HLA Analysis Software Quickly Delivers High-Resolution HLA Types From Genotyping Data

Affymetrix (NASDAQ: AFFX) introduces Axiom ™ HLA Analysis software for automated, high-resolution human leukocyte antigen (HLA) typing from any genotyping dataset containing coverage of the extended major...

Affymetrix To Report Third Quarter 2015 Operating Results On Wednesday October 28, 2015

Affymetrix To Report Third Quarter 2015 Operating Results On Wednesday October 28, 2015

Affymetrix, Inc. (NASDAQ:AFFX) today announced that it will report operating results for the third quarter of 2015 after market close on Wednesday October 28, 2015.

Commit To Buy Affymetrix At $7.50, Earn 10.1% Annualized Using Options

Commit To Buy Affymetrix At $7.50, Earn 10.1% Annualized Using Options

Investors considering a purchase of Affymetrix, Inc. stock, but tentative about paying the going market price of $9.10/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Axiom Rice Genotyping Array (Photo: Business Wire)

Axiom Rice Genotyping Array (Photo: Business Wire)

Affymetrix, Inc. (NASDAQ:AFFX) announced today that it has been selected as the genotyping supplier by the Green Super Rice project coordinated by the Chinese Academy of Agricultural Sciences as part of their effort to...

Affymetrix Reports New Employee Stock Grants

Affymetrix Reports New Employee Stock Grants

Affymetrix (NASDAQ:AFFX) today announced that equity awards were made to 13 new non-executive officer employees as inducement to join Affymetrix.

'Mad Money' Lightning Round: I'm Sticking With My Biotech 'Four Horsemen'

'Mad Money' Lightning Round: I'm Sticking With My Biotech 'Four Horsemen'

Cramer is staying out of Planet Fitness and Chimera Investment but favors Domino's Pizza and General Dynamics.

Jim Cramer's 'Mad Money' Recap: Housing Alone Can't Build a Rally

Jim Cramer's 'Mad Money' Recap: Housing Alone Can't Build a Rally

Too many stocks are levered to overseas issues, especially China, Cramer warns.

Affymetrix Announces 2015 Tumor Profiling Grant Award Recipients To Support Translational Cancer Research

Affymetrix Announces 2015 Tumor Profiling Grant Award Recipients To Support Translational Cancer Research

Affymetrix, Inc. (Nasdaq:AFFX) has announced three recipients of the 2015 United States Affymetrix Tumor Profiling Grant Program.

RSI Alert: Affymetrix (AFFX) Now Oversold

RSI Alert: Affymetrix (AFFX) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Affymetrix Reports Second Quarter 2015 Operating Results

Affymetrix Reports Second Quarter 2015 Operating Results

Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the second quarter of 2015.

Http://www.affymetrix.com

Http://www.affymetrix.com

Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, and Affymetrix (Nasdaq:AFFX), a leading provider of translational research and diagnostic solutions, announce a strategic...

Insider Trading Alert - PQ, ADBE And AFFX Traded By Insiders

Insider Trading Alert - PQ, ADBE And AFFX Traded By Insiders

Stocks with insider trader activity include PQ, ADBE and AFFX